[Clinicopathological characteristics related to Miller/Payne grading system of breast carcinoma after neoadjuvant therapy and establishment of novel prediction models].

Hou, W; Yao, Q; Niu, D F; Xue, W C

Hou, W; Yao, Q; Niu, D F; Xue, W C.

Afiliação

Hou W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Yao Q; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Niu DF; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.
Xue WC; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing 100142, China.

Zhonghua Bing Li Xue Za Zhi ; 51(8): 743-748, 2022 Aug 08.

Article em Zh | MEDLINE | ID: mdl-35922165

Assuntos

Neoplasias da Mama; Terapia Neoadjuvante; Neoplasias da Mama/patologia; Feminino; Humanos; Antígeno Ki-67/metabolismo; Gradação de Tumores; Receptor ErbB-2/metabolismo; Receptores de Estrogênio/metabolismo; Receptores de Progesterona/metabolismo

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias da Mama / Terapia Neoadjuvante Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google